Login to Your Account


Lilly Investing $440M in Second Irish Biopharmaceutical Facility

By Cormac Sheridan
Staff Writer

Tuesday, February 28, 2012
DUBLIN, Ireland – Shrugging off uncertainties stemming from a string of recent – and looming – patent expiries, Eli Lilly and Co. is investing €330 million (US$443 million) in a new biopharmaceutical production facility at its Dunderrow campus, which is located near Kinsale, in County Cork, Ireland.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription